Only 8% of Russian doctors say that the healthcare facilities they work in provide all the necessary personal protective equipment, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 17% say that there have been some interruptions in the provision, but the situation is not critical in general.

Between January and March 2020, Russia manufactured 102.6 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 18 higher than that of the same period in 2019. While the dynamics in monetary terms are promising and not much different from those in late 2019, the dynamics in physical terms (units) are only +0.2%, with 1 bln units manufactured. If calculated in minimum dosage units (MDU), the manufactures volume amounts to 18.6 bln MDUs, with the dynamics of +8.2%.

In Q1 2020, the sales of veterinary drugs in the retail market amounted to 4.88 bln RUB (retail prices, VAT included), with the dynamics of +20.4%. The high dynamics could be explained by a number of factors, in particular average price increase and increased demand. The latter could be attributed to atypical weather earlier this year, hence a shift in demand. If calculated in minimum dosage units (MDU), the market volume is 47.4 bln MDUs, with the dynamics of more than +10%.

Between January and March 2020, Russia imported 2.1 bln RUB worth of veterinary vaccines (customs clearance prices), which is in monetary terms (rubles) 8.4% lower than that of the same period in 2019. The dynamics in physical terms (units) are as low as -24.8%, or, if calculated in dosages, 13.5%. The import volume amounts to 1.13 mln units, or around 10.16 bln dosages.

33% of pharmacists say that they consider online drug sales to be unethical, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 20% noted that they simply would not be able to compete with large online retailers, which makes online development pointless.

Between January and March 2020, Russia imported 60.4 bln RUB worth of ready-made pharmaceuticals (customs clearance prices, VAT included), which is in monetary terms (rubles) 52% lower than that of the same period in 2019. Russia is still using the volumes imported to Russia last year as part of the preparation for the introduction of the labeling system. However, the dynamics of the in-bulk import are +10%, with the volume of 33.1 bln RUB.

Between January and February 2020, Russia imported 2.46 bln RUB worth of veterinary drugs (customs clearance prices), which is monetary terms (rubles) 37% lower than that of the same period in 2019. The import volume of feed supplements amounted to 4.35 bln RUB, with the dynamics of -20%. As for veterinary APIs, the import volume is 306 mln RUB, and the dynamics are -14%.

Between January and February 2020, Russia imported 22.6 bln RUB worth of APIs (customs clearance prices, VAT included), which is in monetary terms (rubles) 18.5% higher than that of the same period in 2019. The dynamics in physical terms are +31%, with 2.2 thousand tons of APIs.

Between January and February 2020, Russia imported 27 bln RUB worth of ready-made pharmaceuticals (customs clearance prices), which is in monetary terms (rubles) 65% lower than that of the same period in 2019. The import volume of the first two months of 2020 turned out to be lower than that of any January, when the activity of the importers is usually the lowest. The dynamics of the in-bulk import in monetary terms are +28%, with the volume of 22.5 bln RUB.